Sarepta Therapeutics, Inc.

NASDAQ:SRPT

123.29 (USD) • At close November 1, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995
Omzet 1,243.336933.013701.887540.099380.833301.034154.5845.4211.2539.75714.21937.32946.9929.4217.58521.25810.9850.1154.7840.430.970.8370.7061.2970.10.20.10.10.1
Kosten van de omzet 150.343139.98997.04963.38256.58634.1937.3530.13146.19494.10390.28451.93335.92727.458000000000-0.4160-0.2-0.5-0.50
Brutowinst 1,092.993793.024604.838476.717324.247266.841147.2315.291-144.941-84.346-76.065-14.60411.0631.96217.58521.25810.9850.1154.7840.430.970.8370.7061.7140.10.40.60.60.1
Brutowinstmarge 0.8790.850.8620.8830.8510.8860.9520.976-115.675-8.645-5.35-0.3910.2350.0671111111111.32112661
Onderzoek- en ontwikkelingskosten 877.387877.09771.182722.343560.909401.843166.707188.272146.39494.23172.90952.40266.86235.97224.39629.00334.7625.34617.11820.73915.28422.41412.7519.2686.76.32.71.72.1
Algemene en administratieve kosten 481.871451.421282.66317.875284.812209.983119.8581.20175.04349.31531.59414.6316.05514.3828.6969.7979.3327.7535.1824.7364.5593.7643.3582.271.71.61.30.60.6
Verkoop- en marketingkosten 28.614.67.700-2.2222.8322.548000000000000000000000
Verkoop-, algemene en administratieve kosten 481.871451.421282.66317.875284.812207.761122.68283.74975.04349.31531.59414.6316.05514.3828.6969.7979.3327.7535.1824.7364.5593.7643.3582.271.71.61.30.60.6
Overige kosten 1.5590.7140.7060.6620.849-0.6561.98200000000000000000.41600.20.50.50
Bedrijfskosten 1,360.8171,329.2251,054.5481,040.88846.57610.469290.442272.021221.437143.546104.50367.03282.91750.35433.09238.79944.09333.09822.325.47419.84326.17816.10911.9558.48.14.52.82.7
Bedrijfsresultaat -267.824-536.201-449.71-564.163-522.323-343.628-171.638-266.73-220.184-133.789-90.284-29.703-35.927-20.934-15.507-27.458-33.108-32.983-17.516-25.044-18.873-25.341-15.403-10.241-8.3-7.7-3.9-2.2-2.6
Bedrijfsresultaat ratio -0.215-0.575-0.641-1.045-1.372-1.141-1.11-49.203-175.725-13.712-6.35-0.796-0.765-0.712-0.882-1.292-3.014-286.085-3.662-58.179-19.46-30.284-21.814-7.894-83-38.5-39-22-26
Totaal overige inkomsten en kosten netto -252.274-153.76230.76211.098-191.55710.13996.573-2.5480.154-2.779-22.027-91.93833.022-11.502-9.198-6.7554.9561.910.840.2663.766-4.478-12.5231.001-0.1-190.40.20
Inkomen voor belasting -520.098-689.963-418.948-553.065-713.88-362.61-48.628-267.265-220.03-135.789-111.985-121.287-2.318-23.953-24.705-23.953-28.152-31.073-16.676-24.778-14.617-29.359-8.278-9.24-8.4-26.7-3.5-2-2.6
Inkomen voor belasting ratio -0.418-0.739-0.597-1.024-1.875-1.205-0.315-49.302-175.603-13.917-7.876-3.249-0.049-0.814-1.405-1.127-2.563-269.518-3.486-57.561-15.071-35.086-11.724-7.122-84-133.5-35-20-26
Belastingkosten 15.87913.525-0.1681.0631.195-0.6922.06-7.624-5.247-1.6920.42491.584-34.90911.2439.6526.411-5.94000-4.2574.01811.5230019-0.3-0.10
Nettowinst -535.977-703.488-418.78-554.128-715.075-361.918-50.688-267.265-220.03-135.789-111.985-121.287-2.318-32.177-25.159-23.953-27.168-31.073-16.676-24.778-14.617-29.359-26.925-9.24-8.3-26.7-3.6-2.1-2.6
Nettowinstmarge -0.431-0.754-0.597-1.026-1.878-1.202-0.328-49.302-175.603-13.917-7.876-3.249-0.049-1.094-1.431-1.127-2.473-269.518-3.486-57.561-15.071-35.086-38.132-7.122-83-133.5-36-21-26
WPA (Winst Per Aandeel) -5.8-8.03-5.15-7.11-9.71-5.46-0.86-5.49-5.2-3.39-3.31-5.14-0.11-1.74-1.62-2.07-3.02-3.54-2.24-4.13-2.94-6.86-7.21-2.96-3.71-13.57-2.14-1.5-2.17
Verwaterde WPA -5.8-8.03-5.15-7.11-9.71-5.46-0.86-5.49-5.2-3.39-3.31-5.14-0.11-1.74-1.62-2.07-3.02-3.54-2.24-4.13-2.94-6.86-7.21-2.96-3.71-13.57-2.14-1.5-2.17
EBITDA -267.824-473.535-412.118-529.276-469.424-342.763-238.731-266.73-220.184-131.01-68.25763.76-68.949-7.969-4.93-9.317-36.05-30.893-15.519-23.156-21.155-19.529-2.323-9.825-7.911.5-3.8-1.9-2.1
EBITDA ratio -0.215-0.508-0.587-0.98-1.233-1.139-1.544-49.203-175.725-13.427-4.81.708-1.467-0.271-0.28-0.438-3.282-267.954-3.244-53.793-21.812-23.339-3.29-7.573-7957.5-38-19-21